ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
OncoCyte Corporation

OncoCyte Corporation (OCX)

3.72
0.00
(0.00%)
At close: April 28 3:00PM
3.72
0.00
( 0.00% )

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 18.6M-1.33M864k-10.87M176k104k115k5.76M
Operating Income 7.13M-8.29M248k-22.94M-9.1M-4.63M-13.52M-33.63M
Pre Tax Income 5.96M-8.33M-6.49M-15.99M-9.13M-4.53M-13.49M-33.51M
Net Income 3.03M-8.33M-7.23M-16.2M-9.13M-4.53M-13.49M-33.51M
Preferred Dividends 00-739k-203k0000
Basic Earnings Per Share (EPS) 00000000
EBIT 5.85M-8.31M244k-22.55M-8.95M-4.52M-13.46M-33.65M
EBITDA 12.53M-7.82M-4.28M-15.86M-8.76M-4.31M-13.18M8.84M
Year End December 30 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0005.23M7.73M31.98M7.27M6.16M
Operating Income -18.85M-15.2M-22.52M-31.26M-74.48M-18M-23.85M-60.87M
Pre Tax Income -19.38M-15.75M-22.43M-31.19M-73.36M-18.61M-24.86M-60.66M
Net Income -19.38M-15.75M-22.43M-29.93M-64.1M-73.42M-28.72M-60.66M
Preferred Dividends 00000-520k-942k0
Basic Earnings Per Share (EPS) -0.616-0.387-0.393-0.433-0.695-0.619-3.477-3.603
EBIT -18.85M-15.11M-22.68M-31.23M-73.38M-18.06M-24.74M-60.58M
EBITDA -18.27M-14.64M-22.18M-30.86M-70.28M5.91M-15.42M-17.41M